Fas antigen, which belongs to a nerve growth factor / tumor necrosis factor receptor superfamily, is a membrane protein that induces apoptosis. In humans, distribution ofFas antigen has been reported on cell lines and lymphocytes. Immunohistochemical studies revealed Fas antigen on the keratinocytes of lesional epidermis in lichenoid drug eruption, erythema multiforme, contact dermatitis, bullous pemphigoid, pemphigus vulgaris, and herpes zoster; it is co-expressed with intercellular adhesion molecule-1. Cultured keratinocytes expressing Fas antigen increased A PoPtosiS, programmed cell death, occurs in embryogenesis, metamorphosis, tissue atrophy, and tumor regression [1, 2] . It is clearly distinguished from cel l death or necrosis resulting from complement attack, hyperthermia, hypoxia, or other severe environmental conditions. Apoptosis is morphologically and biochemically characterized by condensation of the cell, loss of plasma membrane microvilli, shrinki ng and segmentation of the nucleus, and extensive oegradation of chromosomal DNA. A ladder pattern of DNA may be produced by activation of endogenous endonucleases [3] .
Recently, genetic regulation of apoptosis by p53, bcl-2, and c-myc have been reported [4] [5] [6] [7] [8] [9] [10] .
In the immune system, apoptosis plays an important role in clonal deletion of self-reactive T cells in the thymus [11] and in the selection of lymphocytes in the peripheral blood [12, 13] ' Apoptosis has also been documented in pathogenetic conditions such as the death of T cells in human immunodeficiency virus infection [14] or of eosinophils isolated from atopic patients [15] . Radiation, glucocorticoids, tumor necrosis factor, leucyl-Ieucine methyl ester, and fragmentin have also been reported to cause apoptosis [16] [17] [18] [19] [20] . Cytokine signals from the environment such as interferon (IFN)-y, interleukin (IL)-2, IL-5, and IL-6 are known to modulate apoptosis [8, 15, [21] [22] [23] .
Fas antigen, a transmembrane molecule mediating apoptosis, belongs to a nerve growth factor/tumor necrosis factor receptor superfamily [23 -25] . Monoclonal antibody (MoAb) anti-Fas has been shown to cause apoptosis in cells expressing Fas antigen [23] . When the cDNA ofFas antigen was expressed in murine cells, they under- went apoptotic death [24) . Although the physiologic ligand for Fas antigen has not been found, a surface molecule of T cells has been suggested as a candidate [26] . APO-1 has been fo und to be identical with Fas antigen [27 ,28) .
Fas antigen mRNA in mouse was expressed in a limited number of tissues, including the thymus, liver, ovary, and heart [25] . In humans, Fas antigen was demonstrated in cultured cells and freshly isolated lymphocytes [22, 29) , but its distribution on epithelial cells or other cells in vivo has not been well studied. Among diseases, only a lymphoproliferative disorder in the mouse has been shown to be related to Fas antigen (30) . A recent study has shown that anti-Fas has lethal effects in the mouse [31] .
Apoptosis of epidermal keratinocytes was recently reviewed in detail [32] and is known to be an important feature in lichenoid tissue reaction, fixed drug eruption, graft-versus-host reaction, and the effect of ultraviolet radiation [33] . The purpose of this study was to clarify whether Fas antigen is involved in keratinocyte apoptosis. In vivo expression of Pas antigen was studied immunohistochemically and functionally in cultured keratinocytes. We show that Fas antigen is expressed on keratinocytes of lesional epidermis and 011 interferon-gamma (IFN-Y) -stimulated keratinocytes and that apoptosis is induced by anti-Fas antibody.
MATERIALS AND METHODS
Patients Skin specimens were obtained from a total of 31 patients: five cases of lichenoid drug eruption, six cases of erythema multiforme (dermal type), six cases of bullous pemphigoid, five cases of pemphigus vulgaris, six cases of contact dermatitis, and three cases of herpes zoster. Nonlesiollal human skin was obtained from plastic surgery specimens.
Immunohistochemical Studies After fixing with cold acetone and blocking with I-IIO., we stained 4-llm froze n sections in OCT compound with MoAb anti-Fas (CH-11; igM [23] ), MoAb anti-intercellular adhesion molecule-1 (iCAM-1; Cosmo Bio Co. Inc., Tokyo, Japan) or control MoAb (umelev3nt IgM or IgG,) using a streptavidin-biotin-peroxidase staining kit (Nichirei Co. inc., Tokyo,Japan). , Positive/total. Intensity of more than + was desIgnated as positive.
was negligible. The intensity of the staining was rated as -, ±, +? ++, or +++, among which those of more than + were shown as posltlve 111 Table I .
Cell Culture Human foreskin keratinocytes and serum-free culture med·wn containing 0.08 m.M Ca++, extracts of bovine pituitary, and epidermal g~owth factor were obtained from Morinaga Institute of Biological Science (Yo kohama, Kanagawa, J apan) and cultured at 37°C in a humidified atmosphere containing 5% CO 2 . Cells were used for the expcnmcnt when thcy reac hed se miconfluencc.
Flow Cytometry Cultured keratinocytcs :-rere removed from th e culture bottles by incubation wI~h tryPS1l1/ ~thy l enedlamU1etetraacetlc aCid (EDT A) (Morinaga Institute of BIOlogical SCIence) for a ~ew mU1utes (Fas antIgen was sensitive to tryps1l1/EDTA) , and 10% feta l bov1I1e serum was added to stop the action of trypsin. All of the following procedures were performed at 4°C. The cells were washed and resuspended in phosphate-buffered saline (PBS) containing 1.0% bovine serum albumin and 0. Induction of Cell Death by Anti-Fas When cells became semiconfl uent, they were cultured with or without recombinant human IFN-y (Shionogi & Co. Ltd., O sak~, J apan) at a concentratio n of l OJ U / ml for ~4 h. After washing the cells twIce wIth PBS and once wIth cul ture medIUm, anti-Fas was added at a final concentration of 1 Jig/ml, and the culture was continued for an additional 48 h at 37°C. At this time cel ls werc confluent except for those treated with IFN-y and anti-Fas, some of which had detached from the culture surface. As co ntrol, MoAb anti-CD46 (M-1 77, IgG ,), which bound to the keratinocyte cell surface (34] , was added. Cells detached during th e 48-h perIod were recovered by collecting the culture medium and PBS used for rinsing the cultures. Remainin g adherent cells were collected as described above using flow cytometry. The viability of cel ls was determined by trypan blue exclusion. The percent of th e dead cells was expressed as the percent of th~ total cells i~lCludill g both the d~tached and remaining adherent cells. StatIstIcal ana lySIS was performed US111g the Student t test.
To assess DNA fragmentation, we isolated genomic DNA frol11 approximately 3 X t 0 6 cells of each co ndition described above using a DNA extraction kit (Sankojunyaku Co. Ltd., Tokyo, Japan) and anal yzed it on a 2.0% agarose gel stained with ethidium bromide.
EXPRESS ION OF FAS ANTIGEN ON KERATI N OCYTES IN VIVO 331 RESULTS
Immunohistochemical studies showed that Fas antigen was expressed on keratinocytes from lesiona l epidermis in most cases (Fig   1, Table I ). The staining intensity was hig her in lich enoid drug eruption, erythema multiforme, contact dennatitis, and herpes zoster than in bullous pemphigoid and pemphigus vulgaris. Keratinocytes of nonl esional epidermis, obtai ned from patients w ithout inflammation after plastic surgery, showed o nl y faint or no expression of Fas antige n. The keratinocytes also expressed ICAM-t (Fig 1), and the intensity was similar to that ofFas antigen. The distribution ofICAM-l, however, was localized to the basal cell layer, except for erythema multiforme, as reported previously [33] .
By flow cytometry, anti-Fas -positive cells were 8.4% in unstimulated keratinocytes and increased to 34.6% after stimulation with IFN-y for 24 h (Fig 2) . ExpressionofFas antigen and ICAM-l after exposure to different concentrations of IFN-y are shown in Fig 3. The expression ofICAM-l increased from 0.5% to 97.0%.
IFN-y-stimulated keratinocytes were killed by anti-Fas antibody. IFN-y-stimulated cells started to detach fro m the culture surface on the second day after exposure to anti-Fas antibody, and the dead cells from both detached and remai ning cells increased from 10.2% to 31.7% (Fig 4) . Although 
DISCUSSION
Immunohistochemical studies revealed expression ofFas antigen on the keratinocytes of lesional epidermis in a range of inflammatory diseases, the pathogenetic mechanisms of which were entirely different, such as virus infection, lymp hocyte attac k on basal cells, autoantibodies, or delayed-type hyperse nsitivity. Fas antigen and ICAM-1 were co-expressed on these keratinocytes. Variation in staining intensity among the diseases suggested that Fas anti gen might not always be required to cause keratinocyte damage or ICAM-1 expression. Expression of Fas antige n can be induced by IL-2 or IFN-y in lymphocytes o r cell lines [22, 23] , and induction of ICAM-1 on the keratinocytes in eryth ema mu ltiforme, contact dermatitis, and lichenoid tissue reaction may be due to the action of IFN-y [35] . T his suggests that IFN-y might also induce the expression of Fas an tigen on keratinocytes. Keratinocytes of nonlesional epidermis and unstimulated cultured keratinocytes expressed minimal Fas antigen. The expression of Fas antigen was increased on cultured keratinocytes by stimu lation with IFN-y, but the increase was not as significant as that of rCAM-I. Tumor necrosis factor-a had no apparent effect on the expression of Fas antigen (data not shown).
C ultured keratinocytes were susceptible to anti-Fas after treatm ent w ith IFN-y, which can be explained by the increased expression of Fas antigen. Increased susceptibility by IFN-y in cell lines or IL-2 in lymphocytes was also observed [22, 23] . In chronic B-cell lymphocytic leukemia, however, IFN-y inhibits apoptosis [21] .
The process of apoptosis has been well studied in lymphocytes. The first event is DNA fragm.entation, which was observed in less th an 30 min [22] . M orphologic changes occur in several hours [23, 24] , followed by loss of membrane integrity. In IFN-ystimulated keratinocytes, morphologic changes were not observed by light microscopy during the first day of culture with anti-Fas antibody, and were not apparent even on the second day, when cells began to detach. This process is slower than that of lymphocytes. Apoptotic changes were noted in only 30% of keratinocytes. Different sensitivity to anti-Fas antibody has been observed in different cell types [23] , in which dead cells varied from < 25% to > 75%.
Epidermis ca n be a target in many immunologic reactions, al- though the mechanism of the final step leading to the cell death is not yet clear. It is possible that disease-specific induction ofICAM-l is important in triggering these skin diseases and in determining the pattern of the diseases [35] . ICAM-l expression on human keratinocytes can be induced by stimulation with IFN-y, TNF-Q, or ultraviolet radiation [35 -371 . Interactions between ICAM-l on keratinocytes and LFA-l on leukocytes are considered to be important in cellular cytotoxicity [35, 36] . In T-ceH-mediated cytotoxicity, target cells can be killed by apoptosis via Fas antigen [261. The ligand for Fas antigen is thought to be present on lymphocytes but has not yet been identified. Our data suggest a model of keratinocyte cytotoxicity by lymphocytes. First, lymphocytes attach to keratinocytes by means of ICAM-I. Subsequently, apoptosis of keratinocytes is triggered by the adherent lymphocytes via Fas antigen. a   500 w------,---------------- We wish 10 
